These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 19597366

  • 1. Neurohormonal regulation of cardiac ion channels in chronic heart failure.
    Kurokawa J, Abriel H.
    J Cardiovasc Pharmacol; 2009 Aug; 54(2):98-105. PubMed ID: 19597366
    [Abstract] [Full Text] [Related]

  • 2. Evidence for the survival benefit of neurohormonal antagonists in the management of geriatric congestive heart failure.
    Firdaus M, Bukhari N.
    J Okla State Med Assoc; 2003 Mar; 96(3):133-9. PubMed ID: 12688226
    [Abstract] [Full Text] [Related]

  • 3. Neurohormonal activation in congestive heart failure and the role of vasopressin.
    Chatterjee K.
    Am J Cardiol; 2005 May 02; 95(9A):8B-13B. PubMed ID: 15847852
    [Abstract] [Full Text] [Related]

  • 4. Chronic heart failure as a metabolic disorder.
    Anker SD, Al-Nasser FO.
    Heart Fail Monit; 2000 May 02; 1(2):42-9. PubMed ID: 12634873
    [Abstract] [Full Text] [Related]

  • 5. Remodelling of cardiac repolarization: how homeostatic responses can lead to arrhythmogenesis.
    Michael G, Xiao L, Qi XY, Dobrev D, Nattel S.
    Cardiovasc Res; 2009 Feb 15; 81(3):491-9. PubMed ID: 18826964
    [Abstract] [Full Text] [Related]

  • 6. Neurohormonal Regulation of IKs in Heart Failure: Implications for Ventricular Arrhythmogenesis and Sudden Cardiac Death.
    Shugg T, Hudmon A, Overholser BR.
    J Am Heart Assoc; 2020 Sep 15; 9(18):e016900. PubMed ID: 32865116
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms of neurohormonal activation in chronic congestive heart failure: pathophysiology and therapeutic implications.
    Dávila DF, Núñez TJ, Odreman R, de Dávila CA.
    Int J Cardiol; 2005 Jun 08; 101(3):343-6. PubMed ID: 15907399
    [Abstract] [Full Text] [Related]

  • 8. Cocaine cardiotoxicity: a review of the pathophysiology, pathology, and treatment options.
    Phillips K, Luk A, Soor GS, Abraham JR, Leong S, Butany J.
    Am J Cardiovasc Drugs; 2009 Jun 08; 9(3):177-96. PubMed ID: 19463023
    [Abstract] [Full Text] [Related]

  • 9. Neurohormonal inhibition in heart failure: insights from recent clinical trials.
    Gheorghiade M, De Luca L, Bonow RO.
    Am J Cardiol; 2005 Dec 19; 96(12A):3L-9L. PubMed ID: 16399087
    [Abstract] [Full Text] [Related]

  • 10. Using Cardicor as first-line therapy in heart failure : CiBis iii.
    Cardiovasc J Afr; 2009 Dec 19; 20(1):78. PubMed ID: 19382368
    [No Abstract] [Full Text] [Related]

  • 11. Two new culprits in cardiovascular disease: QT dispersion and aldosterone.
    Struthers AD.
    J Hum Hypertens; 1995 Aug 19; 9(8):659-61. PubMed ID: 8523384
    [Abstract] [Full Text] [Related]

  • 12. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
    Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G, Butler J.
    J Am Coll Cardiol; 2009 Nov 03; 54(19):1747-62. PubMed ID: 19874988
    [Abstract] [Full Text] [Related]

  • 13. [Chronic heart failure (IV). The neurohormonal factors in chronic heart failure. Their clinical importance and therapeutic implications].
    Rayo I, Marín Huerta E.
    Rev Esp Cardiol; 1991 Dec 03; 44(10):656-71. PubMed ID: 1686945
    [No Abstract] [Full Text] [Related]

  • 14. [Chronic heart failure and sudden death: the message of CIBIS-III].
    Dequarti MC, Poggio L, Vanoli E.
    Recenti Prog Med; 2007 Dec 03; 98(12):638-45. PubMed ID: 18369041
    [Abstract] [Full Text] [Related]

  • 15. What causes sudden death in heart failure?
    Tomaselli GF, Zipes DP.
    Circ Res; 2004 Oct 15; 95(8):754-63. PubMed ID: 15486322
    [Abstract] [Full Text] [Related]

  • 16. [Heart hypertrophy and heart failure--experimental findings for arrhythmogenesis].
    Milberg P, Pott C, Eckardt L, Breithardt G.
    Dtsch Med Wochenschr; 2008 Dec 15; 133 Suppl 8():S285-9. PubMed ID: 19085808
    [Abstract] [Full Text] [Related]

  • 17. Renal hemodynamics in heart failure: implications for treatment.
    Rea ME, Dunlap ME.
    Curr Opin Nephrol Hypertens; 2008 Jan 15; 17(1):87-92. PubMed ID: 18090676
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms of disease: ion channel remodeling in the failing ventricle.
    Nass RD, Aiba T, Tomaselli GF, Akar FG.
    Nat Clin Pract Cardiovasc Med; 2008 Apr 15; 5(4):196-207. PubMed ID: 18317475
    [Abstract] [Full Text] [Related]

  • 19. Neurohormonal activation in the treatment of congestive heart failure: basis for new treatments?
    Pool PE.
    Cardiology; 1998 Jul 15; 90(1):1-7. PubMed ID: 9693163
    [Abstract] [Full Text] [Related]

  • 20. Chemosensitivity in chronic heart failure.
    Ponikowski P, Banasiak W.
    Heart Fail Monit; 2001 Jul 15; 1(4):126-31. PubMed ID: 12634897
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.